Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C, Llamosas E, Knipprath-Meszaros A, Schoetzau A, Obermann E, Fuenfschilling M, Caduff R, Fink D, Hacker N, Ward R, Heinzelmann-Schwarz V, Ford C.
Henry C, et al. Among authors: fink d.
Oncotarget. 2015 Nov 24;6(37):40310-26. doi: 10.18632/oncotarget.5643.
Oncotarget. 2015.
PMID: 26515598
Free PMC article.